Quintiles, the world’s largest life science services company, is the No. 1 clinical research organization in the world for the third time in four years. So declared industry executives in and other experts who were the voters in the annual Vaccine Industry Excellence Awards.
The Durham-based global conglomerate was recognized Wednesday night at the annual World Vaccine Congress in Washington.
Quintiles (NYSE: Q) was cited for:
- Range of services provided in niche and core therapeutic areas
- Methods of performance improvement or introduction of new services
- Attention to and quality of relationships with clients
- Reaching of milestones and final/ongoing outcomes
- Building and maintaining existing and long-term partnerships
“We are honored to once again receive this prestigious award reflecting the insight of many from across the biopharmaceutical industry,” said Phil Breitfeld, vice president and head of the Therapeutic Centers of Excellence at Quintiles, in a statement. “It is clear to us all that the healthcare industry has a tremendous opportunity to conquer the global burden of disease. We’re proud to be working alongside our customers to develop and commercialize vaccines and anti-infective products that contribute to those efforts and can help create a healthier world.”
